Evolvere BioSciences YC 申请

Summer 2024Active

Evolvere BioSciences 在 Summer 2024 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Summer 2024
行业: HealthcareTherapeutics
团队规模: 3
状态: Active
已发布: 2024

创始人

Adam WinnifrithFounder
Piotr JedryszekFounder
Weronika SlesakFounder

Evolvere BioSciences 做什么

🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. 🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️. We are a team of biochemists and evolutionary biologists who met at the University of Oxford.

Evolvere BioSciences 的 YC 申请，重建版

Y Combinator 申请

Evolvere BioSciences，Summer 2024 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Evolvere BioSciences

Describe what your company does in 50 characters or less.

Next-gen antibiotics outpace bacterial resistance

What is your company going to make? Please describe your product and what it does or will do.

We build computational models that predict how bacteria will evolve resistance to antibiotics. Using those forecasts, we design antibiotics that bacteria can't easily outsmart, targeting only harmful bacteria and sparing beneficial microbes and human cells.

Where do you live now, and where would the company be based after YC?

We live in Oxford, England, and would base the company there after YC.

Explain your decision regarding location.

We're rooted in Oxford because we met here at the University of Oxford as biochemists and evolutionary biologists. The region's scientific environment and access to expertise are vital for our work.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Evolvere BioSciences 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Evolvere BioSciences 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Evolvere BioSciences 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Evolvere BioSciences 是哪个 YC 批次的？

Evolvere BioSciences 是 Y Combinator Summer 2024 批次的成员。

谁创立了 Evolvere BioSciences？

Evolvere BioSciences 由 Adam Winnifrith, Piotr Jedryszek, Weronika Slesak 创立。

Evolvere BioSciences 做什么？

Making Next-Generation Antibiotics that Outpace Bacterial Evolution

如何阅读完整的重建申请？

创建免费的 Round Funded 账户。YC Insights 中包含 Evolvere BioSciences 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。